WorksheetsCC-P11
Total questions: 177
Worksheet time: 1hrs 29mins
Name
Class
Date
1.
Largest concentration in the myocardium; usually seen in the left ventricle.
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
2.
O2-carrying protein in skeletal and cardiac muscles; detected sooner than troponin but not cardiac specific
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
3.
Cardiac-specific and show sustained elevation; TnI with greater cardiac specificity than TnT
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
4.
Gold standard for ACS/AMI
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
5.
Negative predictor of AMI (1st 3 hour)
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
6.
5-kDa protein expressed by neutrophils and epithelial cells including those of the proximal tubule
a)
Neutrophil gelatinase-associated lipocalin
b)
Neuronal thread protein, AMyloid B42, Tau protein
7.
Early predictor of AKI
a)
Neutrophil gelatinase-associated lipocalin
b)
Neuronal thread protein, AMyloid B42, Tau protein
8.
Biomarkers of alzheimers disease
a)
Neutrophil gelatinase-associated lipocalin
b)
Neuronal thread protein, AMyloid B42, Tau protein
9.
Decreased
a)
Neuronal thread protein
b)
Amyloid B2
c)
Tau protein
10.
Increased
a)
Neuronal thread protein
b)
Amyloid B2
c)
Tau protein
11.
Useful in cases where creatinine measurement is not appropriate
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
12.
Biomarker of bacteremia and sepsis
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
13.
Increases early in infection (3-6 hours) and has a greater specificity for infection than CRP.
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
14.
Endogenous markers of GFR
a)
Myoglobin
b)
Cardiac troponins
c)
Cystatin C
d)
Procalcitonin
e)
B trace protein
15.
Structurally related neurohormones that affect body fluid homeostasis and blood pressure
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
16.
Popular marker for congestive heart failure.
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
17.
Natriuresis and diuresis
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
18.
Biologically active hormone
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
19.
Excellent marker for early heart failure.
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
20.
B-type natriuretic peptide is a biologically ___ hormone
a)
active
b)
inactive
21.
N-terminal (NT) - prohormone is a biologically ___ prohormone released from the same precursor of BNP
a)
active
b)
inactive
22.
B-type natriuretic peptide is an excellent market for ___ detection or diagnosis of heart failure.
a)
early
b)
late
23.
It is biologically inactive prohormone released from the same precursor of BNP
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
24.
It is responsible for monitoring heart failure.
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
25.
Detection of decreased angiotensin and norepinephrine synthesis are purpose of which of the following proteins?
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
26.
Brain Natriuretic Peptide is a popular marker of...
a)
Iron deficiency anemia
b)
Hemochromatosis
c)
Billiary obstruction
d)
Congestive heart failure
27.
Brain Natriuretic peptide is the __ concentration in the myocardium.
a)
Largest
b)
Smallest
28.
a. associated with cell adhesion, tissue differentiation, growth, and wound healing.
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
29.
Plasma fibronectin is considered as a nutritional marker
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
30.
Demonstrates a wide variety of cellular interactions, e.g. cell adhesion, differentiation, growth, and wound healing
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
31.
An example of a nutritional marker.
a)
Fibronectin
b)
Fetal fibronectin
c)
Plasma fibronectin
32.
Its production is from the boundary of the amniotic sac and decidua
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
33.
Detected in the early pregnancy
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
34.
Becomes undetectable after 24 weeks
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
35.
Associated with premature delivery
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
36.
Non-invasive; sample is cervico-vaginal secretions
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
37.
It is produced from the boundary of the amniotic sac and decidua. Typically detected in early pregnancy but after 24 weeks, it becomes undetectable. This is also a marker of premature delivery and a non-invasive test; sample is cervico-vaginal secretions
a)
Brain Natriuretic Peptide
b)
N-terminal (NT) pro hormone BNP (NT-proBNP)
c)
Fibronectin
d)
Fetal Fibronectin
38.
Fetal fibronectin becomes undetectable after
a)
20 weeks
b)
23 weeks
c)
24 weeks
d)
30 weeks
39.
Early pregnancy - Fetal fibronectin
a)
Detectable
b)
Undetectable
40.
After 24 weeks... - Fetal fibronectin
a)
Detectable
b)
Undetectable
41.
It is produced in adipocytes.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
42.
This protein is inversely related to BMI
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
43.
This protein is produced in adipocytes. It is inversely related to BMI and results that shows lower levels of this protein indicates a risk for heart disease, type 2 diabetes mellitus, metabolic syndrome, and obesity.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
44.
Lower levels of this protein indicates a risk for heart disease, type 2 diabetes mellitus, metabolic syndrome, and obesity.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
45.
Helps in distributing fats to skin and not visceral organs
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
46.
A marker of CSF leakage in cases of otorrhea and rhinorrhea
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
47.
What is the marker of CSF leakage in cases of otorrhea and rhinorrhea? Also, this protein is considered as a promising marker in diagnosing peri-lymphatic fluid fistulas.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
48.
Correlates with serum cystatin C and urine microproteins; not influenced by glucocorticoid therapy
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
49.
A biochemical marker of bone resorption or osteoporosis
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
50.
Proteolytic fragments of collagen I
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
51.
This protein increases at menopause.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
52.
It is a biochemical marker of bone resorption which also increases at menopause.
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
53.
Insoluble fibrous protein
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
54.
Alteration in secondary structure
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
55.
It is an insoluble fibrous protein. Alteration in secondary structure would lead to a condition called something na may doisis sa dulo :(((((
a)
Adiponectin
b)
B-trace protein
c)
Cross-linked C-telopeptides (CTXs)
d)
Amyloid
56.
It is considered as the chief metabolic organ in the body.
a)
Kidneys
b)
Liver
c)
Lungs
d)
Heart
57.
Its purpose is to abolish the liver tissue function, more than 80% of the liver must be destroyed.
a)
Kidneys
b)
Liver
c)
Lungs
d)
Heart
58.
TP, Alb, PT
a)
Synthetic function
b)
Conjugation
c)
Detoxification
d)
Excretory and secretory
e)
Storage
59.
Bilirubin
a)
Synthetic function
b)
Conjugation
c)
Detoxification
d)
Excretory and secretory
e)
Storage
60.
Removing ammonia
a)
Synthetic function
b)
Conjugation
c)
Detoxification
d)
Excretory and secretory
e)
Storage
61.
Releasing bilirubin
a)
Synthetic function
b)
Conjugation
c)
Detoxification
d)
Excretory and secretory
e)
Storage
62.
"a"
a)
Synthetic function
b)
Conjugation
c)
Detoxification
d)
Excretory and secretory
e)
Storage
63.
Liver function tests are usually based on which principle?
a)
Colorimetry
b)
Fluorometry
c)
Photometry
d)
Turbidimetry
64.
Reflectometry, turbidimetry, nephelometry, etc.
a)
Carbon, Hydrogen, Oxygen, Nitrogen
b)
Amino acids
c)
Peptide bonds
d)
Protein
65.
Biuret
a)
Carbon, Hydrogen, Oxygen, Nitrogen
b)
Amino acids
c)
Peptide bonds
d)
Protein
66.
Lowry
a)
Carbon, Hydrogen, Oxygen, Nitrogen
b)
Amino acids
c)
Peptide bonds
d)
Protein
67.
UV consumption
a)
Carbon, Hydrogen, Oxygen, Nitrogen
b)
Amino acids
c)
Peptide bonds
d)
Protein
68.
Kjeldahl
a)
Carbon, Hydrogen, Oxygen, NITROGEN
b)
Amino acids
c)
Peptide bonds
d)
Protein
69.
Chemiluminiscence
a)
Carbon, Hydrogen, Oxygen, NITROGEN
b)
Amino acids
c)
Peptide bonds
d)
Protein
70.
Kjeldahl
a)
Chemiluminiscence
b)
UV absorption
c)
Biuret
d)
METRY
71.
measurement of absorbance at 280 nm owing mostly to Trp, Tyr, and Phe
a)
Chemiluminiscence
b)
UV absorption
c)
Biuret
d)
METRY
72.
Lowry
a)
Chemiluminiscence
b)
UV absorption
c)
Biuret
d)
METRY
73.
Peptide bonds
a)
Chemiluminiscence
b)
UV absorption
c)
Biuret
d)
METRY
74.
Proteins
a)
Chemiluminiscence
b)
UV absorption
c)
Biuret
d)
METRY
75.
Proteins
a)
Kjeldahl; chemiluminiscence
b)
Lowry; UV absorption
c)
Biuret
d)
Nephlometry, turbidimetry, reflectometry
76.
Peptide bonds
a)
Kjeldahl; chemiluminiscence
b)
Lowry; UV absorption
c)
Biuret
d)
Nephlometry, turbidimetry, reflectometry
77.
Amino acids
a)
Kjeldahl; chemiluminiscence
b)
Lowry; UV absorption
c)
Biuret
d)
Nephlometry, turbidimetry, reflectometry
78.
CHON (NITROGEN)
a)
Kjeldahl; chemiluminiscence
b)
Lowry; UV absorption
c)
Biuret
d)
Nephlometry, turbidimetry, reflectometry
79.
It is the Standard Reference method
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
80.
It is the Standard/ultimate Reference method. Used for the measurement of nitrogen content. Also, 1 gram of this analyte is equal to 6.54 grams of protein.
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
81.
measurement of the shift in absorbance when proteins bind to a dye
a)
Refractometry
b)
Turbidimetry
c)
Folin-Ciocalteau (Lowry method)
d)
Ninhydrin method
e)
Dye-binding method
82.
formation of violet color in the presence of amino groups
a)
Refractometry
b)
Turbidimetry
c)
Folin-Ciocalteau (Lowry method)
d)
Ninhydrin method
e)
Dye-binding method
83.
oxidation of phenolic groups producing a blue color
a)
Refractometry
b)
Turbidimetry
c)
Folin-Ciocalteau (Lowry method)
d)
Ninhydrin method
e)
Dye-binding method
84.
measurement of the change in optical density following precipitation with Trichloroacetic acid (TCA), Sulfosalicylic acid, BC
a)
Refractometry
b)
Turbidimetry
c)
Folin-Ciocalteau (Lowry method)
d)
Ninhydrin method
e)
Dye-binding method
85.
measurement of refractive index due to proteins in solution
a)
Refractometry
b)
Turbidimetry
c)
Folin-Ciocalteau (Lowry method)
d)
Ninhydrin method
e)
Dye-binding method
86.
Used for the measurement of nitrogen content
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
87.
1 gram of this analyte is equal to 6.54 grams of protein.
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
88.
O2 + Sample - heat 1,100+=20 degree C --> Nitric Oxide+ ozone (O3) >> NO2--- ground state >> Emission = concentration
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
89.
O2 + Sample - heat 1,100+=20 degree C --> Nitric Oxide+ ozone (O3) >> NO2--- ground state >> Emission = concentration
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
90.
It is the most widely used method.
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
91.
It measures based on 2 peptide bonds.
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
92.
Cupric ions + Di peptide + Na+ K+ Tartrate (Rochelle salt) + potassium iodide + NaOH = violet color at 540 nm > protein concentration
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
93.
It is the most widely used method. It measures based on 2 peptide bonds. VIA
Cupric ions + Di peptide + Na+ K+ Tartrate (Rochelle salt) + potassium iodide + NaOH = violet color at 540 nm > protein concentration
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
94.
It has the highest analytical sensitivity
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
95.
This method is based on tyrosine, tryptophan, and histidine
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
96.
This method is based on tyrosine, tryptophan, and histidine. Also, it has the highest analytical sensitivity.
a)
Kjeldahl Method
b)
Chemiluminescence
c)
Biuret Method
d)
Folin-Ciocalteu Method
97.
Biuret nm
a)
500 nm
b)
540 nm
c)
280 nm
98.
UV absorption nm
a)
500 nm
b)
540 nm
c)
280 nm
99.
Tryptophan, tyrosine, and phenylalanine absorbs at ___ nm.
a)
500 nm
b)
540 nm
c)
280 nm
100.
Tryptophan, tyrosine, and phenylalanine absorbs at 280 nm.
a)
Ultraviolet absorption
b)
Electrophoresis
101.
For monoclonal spikes
a)
Ultraviolet absorption
b)
Electrophoresis
102.
Pulmonary emphysema would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Alpha 2 globulin band spike
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
103.
Nephrotic syndrome would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Alpha 2 globulin band spike
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
104.
Iron Deficiency anemia would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Alpha 2 globulin band spike
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
105.
Portal cirrhosis would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Alpha 2 globulin band spike
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
106.
Multiple myeloma would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Alpha 2 globulin band spike
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
107.
Inflammation would show which of the following abnormal serum electrophoretic pattern?
a)
Alpha 1 globulin flat curve
b)
Spikes of alpha 1, alpha 2, and Beta region
c)
Small spikes in Beta region
d)
Beta-gamma bridging
e)
Gamma spike
108.
Computed
a)
Serum + sodium sulfate
b)
Globulin
c)
Albumin
109.
Most commonly used dye for albumin
a)
Methyl orange
b)
2,4-HABA
c)
BCG
d)
BCP
110.
less sensitive; subject to interferences dye for albumin
a)
Methyl orange
b)
2,4-HABA
c)
BCG
d)
BCP
111.
nonspecific (globulins may also bind) dye for albumin
a)
Methyl orange
b)
2,4-HABA
c)
BCG
d)
BCP
112.
specific, sensitive, precise dye for albumin
a)
Methyl orange
b)
2,4-HABA
c)
BCG
d)
BCP
113.
Measured
a)
Serum + sodium sulfate
b)
Globulin
c)
Albumin
114.
Supernatant
a)
Serum + sodium sulfate
b)
Globulin
c)
Albumin
115.
Precipitate
a)
Serum + sodium sulfate
b)
Globulin
c)
Albumin
116.
Albumin
a)
Supernatant
b)
Precipitate
117.
Globulin
a)
Supernatant
b)
Precipitate
118.
Use of salicyclic and or Trichloroacetic acid
a)
Turbidimetric and nephelometric
b)
Refractometry
c)
Prothrombin time
119.
Measurement of refractive index due to solutes in serum
a)
Turbidimetric and nephelometric
b)
Refractometry
c)
PRothrombin time
120.
Intrahepatic vs extrahepatic
a)
Turbidimetric and nephelometric
b)
Refractometry
c)
PRothrombin time
121.
Indicates loss of synthetic ability of the liver
a)
Long PT
b)
Short PT
122.
Can no longer create vitamin K coagulation factors (II, V, VII, IX, X)
a)
Extrahepatic
b)
Intrahepatic
123.
PT is prolonged
a)
Extrahepatic
b)
Intrahepatic
124.
Pre-hepatic, post hepatic
a)
Extrahepatic
b)
Intrahepatic
125.
Can still create vitamin K coagulation factors (II, V, VII, IX, X)
a)
Extrahepatic
b)
Intrahepatic
126.
PT is normal
a)
Extrahepatic
b)
Intrahepatic
127.
Intrahepatic
a)
Normal PT
b)
Prolonged PT
c)
Shortened PT
128.
Extrahepatic
a)
Normal PT
b)
Prolonged PT
c)
Shortened PT
129.
a)
Nephrotic syndrome
b)
Acute phase proteins
c)
Alpha 1 antitrypsin deficiency
d)
Hypogammaglobulinemia
130.
a)
Nephrotic syndrome
b)
Acute phase proteins
c)
Alpha 1 antitrypsin deficiency
d)
Hypogammaglobulinemia
131.
a)
Nephrotic syndrome
b)
Acute phase proteins
c)
Alpha 1 antitrypsin deficiency
d)
Hypogammaglobulinemia
132.
a)
Nephrotic syndrome
b)
Acute phase proteins
c)
Alpha 1 antitrypsin deficiency
d)
Hypogammaglobulinemia
133.
a)
Monoclonal gammopathy
b)
Polyclonal gammopathy
c)
Severe hepatic disease
d)
Liver cirrhosis
134.
a)
Monoclonal gammopathy
b)
Polyclonal gammopathy
c)
Severe hepatic disease
d)
Liver cirrhosis
135.
a)
Monoclonal gammopathy
b)
Polyclonal gammopathy
c)
Severe hepatic disease
d)
Liver cirrhosis
136.
a)
Monoclonal gammopathy
b)
Polyclonal gammopathy
c)
Severe hepatic disease
d)
Liver cirrhosis
137.
Identify the pattern:
a)
Normal pattern
b)
Nephrotic syndrome
c)
Protein-losing enteropathy
d)
Hepatic cirrhosis (polyclonal gammopathy)
138.
Identify the pattern:
a)
Normal pattern
b)
Nephrotic syndrome
c)
Protein-losing enteropathy
d)
Hepatic cirrhosis (polyclonal gammopathy)
139.
Identify the pattern:
a)
Normal pattern
b)
Nephrotic syndrome
c)
Protein-losing enteropathy
d)
Hepatic cirrhosis (polyclonal gammopathy)
140.
Identify the pattern:
a)
Normal pattern
b)
Nephrotic syndrome
c)
Protein-losing enteropathy
d)
Hepatic cirrhosis (polyclonal gammopathy)
141.
Identify the pattern
a)
Immediate response pattern
b)
Delayed response pattern
c)
Hypogammaglobulinemia
d)
Paraprotein (Monoclonal gammopathy)
142.
Identify the pattern
a)
Immediate response pattern
b)
Delayed response pattern
c)
Hypogammaglobulinemia
d)
Paraprotein (Monoclonal gammopathy)
143.
Identify the pattern
a)
Immediate response pattern
b)
Delayed response pattern
c)
Hypogammaglobulinemia
d)
Paraprotein (Monoclonal gammopathy)
144.
Identify the pattern
a)
Immediate response pattern
b)
Delayed response pattern
c)
Hypogammaglobulinemia
d)
Paraprotein (Monoclonal gammopathy)
145.
nephrotic syndrome
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
146.
extensive burns
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
147.
blood loss
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
148.
protein-losing enteropathy
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
149.
undernutrition (wasting, stunting, underweight)
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
150.
resulting diet-related noncommunicable diseases
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
151.
overweight / obese
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
152.
inadequate vitamins or minerals
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
153.
liver disease e.g. hepatic cirrhosis (polyclonal gammopathy)
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
154.
Infection
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
155.
Inflammation
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
156.
Trauma
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
157.
Burns
a)
Increased protein loss
b)
Malnutrition or malabsorption
c)
Decreased synthesis
d)
Increased Catabolism
158.
Serum amyloid A
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
159.
C3
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
160.
haptoglobin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
161.
A1-antitrypsin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
162.
Pre-albumin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
163.
Transferrin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
164.
Albumin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
165.
RBP
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
166.
CRP
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
167.
Fibrinogen
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
168.
Ceruloplasmin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
169.
A1-antichymotrypsin
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
170.
A1 acid glycoprotein
a)
Type 1 Positive APR
b)
Type 2 Positive APR
c)
Negative APR
171.
Increased protein loss
a)
Hypoproteinemia
b)
Hyperproteinemia
172.
Immunodeficiency
a)
Hypoproteinemia
b)
Hyperproteinemia
173.
Monoclonal gammopathy
a)
Hypoproteinemia
b)
Hyperproteinemia
174.
Dehydration
a)
Hypoproteinemia
b)
Hyperproteinemia
175.
Increased catabolism
a)
Hypoproteinemia
b)
Hyperproteinemia
176.
Decreased synthesis
a)
Hypoproteinemia
b)
Hyperproteinemia
177.
Malnutrition/malabsorption
a)
Hypoproteinemia
b)
Hyperproteinemia
100 %
